Di Giorgio, E., Wang, L., Xiong, Y., Akimova, T., Christensen, L. M., Han, R., Samanta, A., Trevisanut, M., Bhatti, T. R., Beier, U. H. and Hancock, W. W. Mef2d sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity. Journal Of Clinical Investigation. 2020. doi: 10.1172/jci135486
Menu
